📰 Pharma Services News
Page 8 - Pharma Services News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Services. Real-time updates on events, politics, business and more.
November 27, 2023
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
November 22, 2023
Think Research Announces Date of Third Quarter and Year-to-date 2023 ...
November 21, 2023
/PRNewswire/ -- The clinical trial supplies market size is expected to grow by USD 1.19 billion from 2022 to 2027. In addition, the momentum of the market will...
November 17, 2023
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The
November 14, 2023
/PRNewswire/ -- The "Global Pharmaceutical Contract Manufacturing Market - Forecast to 2030" report has been added to ResearchAndMarkets.coms offering....
November 14, 2023
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The
November 10, 2023
After steadying during Q2, it appears the overall volume of deals in the healthcare industry declined in Q3 compared with Q2, and year-to-date 2023 is still down from last year. A...
November 10, 2023
Think Research Announces Agreement for Subsequent Advance Under Existing ...
November 9, 2023
NeoGenomics (NASDAQ:NEO – Free Report) had its target price upped by Morgan Stanley from $16.00 to $17.00 in a research report report published on Wednesday morning, Benzinga reports. The firm currently has an equal weight rating on the medical research company’s stock. Other equities research analysts have also issued reports about the company. Piper Sandler […]
November 9, 2023
Los Angeles Capital Management LLC purchased a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 24,201 shares of the medical research company’s stock, valued at approximately $389,000. Several other large investors have also recently […]